Hatvani Albert Schweitzer Korhaz-Rendelointezet

The trials here

What the trial at this site is about, from its registry record.

Conditions

• Coronary artery disease
• Heart failure

Closed trials

• Completed

  Study to Assess Efficacy and Safety of CDR132L in Patients With Reduced Left Ventricular Ejection Fraction After Myocardial Infarction

  NCT05350969· Phase 2· Cardior Pharmaceuticals GmbH· Source